In this series of videos Dr. Graham Sher, CEO of Canadian Blood Services talks about plasma and its significance for Canadian patients.
What is Canadian Blood Services' role in plasma collection?
Canadian Blood Services collects plasma for two purposes. We collect plasma for transfusion directly into patients to treat bleeding disorders, trauma and other indications. We also collect plasma to be used as a raw material to produce a category of drugs called plasma protein products.
Are products made from plasma from paid donors safe?
Paying plasma donors is not an issue of safety. The finished products that come from the commercial paid plasma industry are inordinately safe, and there has been no documented evidence of any viral transmission for almost three decades or more from these products.
What is Canadian Blood Services doing to address Canada's sufficiency in plasma?
Canadian Blood Services is in the process of developing a plan to expand the amount of plasma we collect in Canada to make plasma products, which we will discuss with the provinces and territories.
Should Canada be 100 per cent sufficient in plasma?
We have learned that there is a risk benefit to assess to determine an appropriate level of sufficiency versus 100 per cent sufficiency. We have done a lot of work over the last number of years to model an appropriate balance of risks based on a variety of factors.
How much does Canada rely on commercial paid plasma market, which has paid donors?
Only about one-quarter of the immune globulin products we distribute are made with plasma from unpaid donors. The remaining three-quarters of these products are made from plasma from paid donors in the United States.